Adolescent substance use disorders and comorbidity

Pediatric Clinics of North America

Volumn 49, Issue 2, 2002, Pages 463-477

  Simkin, Deborah R ^a,b  

^a Private practice   (United States)

^b American Academy of Child and Adolescent Psychiatry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; FLUOXETINE; GUANFACINE; LITHIUM; NALTREXONE; NORTRIPTYLINE; PEMOLINE; SEROTONIN UPTAKE INHIBITOR; VALPROATE SEMISODIUM; VENLAFAXINE;

AFFECTIVE NEUROSIS; ANXIETY NEUROSIS; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD BEHAVIOR; COMORBIDITY; CULTURAL FACTOR; DEPRESSION; DRUG DEPENDENCE; EATING DISORDER; EDUCATION; GENETIC SUSCEPTIBILITY; HUMAN; INTERPERSONAL COMMUNICATION; LEARNING DISORDER; MANIC DEPRESSIVE PSYCHOSIS; MOTIVATION; POSTTRAUMATIC STRESS DISORDER; PRIMARY MEDICAL CARE; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR;

ADOLESCENT; ADOLESCENT BEHAVIOR; HUMANS; MENTAL DISORDERS; RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 0036228077     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(01)00014-1     Document Type: Review

References (87)

1. Youth drug abuse treatment: A controlled outcome study
2. Types of alcoholics: I. Evidence for an empirically derived topology based on indicators of vulnerability and solvent
3. Treating suicidal patients with bipolar disorder: Reducing suicide risk with lithium
4. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8 year old prospective study
5. Peer influence on adolescent drug use
6. Familial antecedents of adolescent drug use: A developmental perspective
7. Is abuse during childhood a risk factor for developing substance abuse problems as an adult
8. Pharmacotherapy of ADHD reduces risk for substance use disorder
9. Long term follow up of randomized drug abuse prevention trial in a white middle class population
10. Alcohol, firearms, and suicide among youth
11. Psychiatric risk factors for adolescent suicide: A case control study
12. Initiation into adolescent marijuana use
13. Risk factors for completed suicide among adolescents with a lifetime history of substance abuse: A case control study
14. Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers
15. Drug use in women with anorexia and bulimia nervosa
16. Characteristics of bulimic women with and without alcoholism
17. Age of alcoholism onset I relationship to psychopathology
18. Age of onset of alcoholism: II. Relationship to susceptibility of serotonin precussor availability
19. An adoption study of genetic and environmental factors in drug use
20. Adolescent versus adult onset and the development of substance use disorders in males
21. Impact of parent monitoring on initiation of drug use through later childhood
22. Neurogenetic adoptive mechanisms in alcoholism
23. Psychopathology in adopted out children of alcoholics. The Stockholm adoption study
24. Understanding gender differences in adolescent drug abuse: Issues of comorbidity and family functioning
25. Effects of ADHD, conduct disorder and gender on substance use abuse in adolescents
26. Age of first alcohol use: A risk factor for the development of alcohol disorders
27. Prevalence and risk factors for Post traumatic stress disorder among chemically dependent adolescents
28. Problem drinking and the dimension of involvement with: A Gultman scalogram analysis of adolescent drug use
29. Contributions of the social context to the development of adolescent substance use: A multivariate latent growth modeling approach
30. Frequency and co-morbidity of social fears in adolescents
31. Double blind and placebo controlled study of lithium for adolescent bipolar disorders with secondary substance dependence
32. Neuropsychological deficits in female adolescents with a substance use disorder: Better accounted for by conduct disorder?
33. Comorbidity of substance use and post traumatic stress disorder in a community sample of adolescents
34. Analysis and reconceptualization of resilence
35. Drinking problems in adopted and nonadopted sons of alcoholics
36. Conduct disorder substance use disorders and coexisting conduct and substance use disorders in adolescent patients
37. Cannabis, vulnerability and the onset of schizophrenia: An epidemiological perspective
38. Prevention programs: What are the critical factors that spell success?
39. Affective and social influence approaches to the prevention of multiple substance abuse among seventh grade students: Results from Project SMART
40. The natural history of alcohol abuse: Implications for definition of alcohol use disorders
41. Serotonin dysfunction, negative mood states and response to alcohol
42. The development of alcohol and other substance use: A gender study of family and peer context
43. Psychiatric comorbidity in hospitalized adolescent substance abusers
44. Psychological distress, problem behaviors, and family functioning of sexually abused adolescent inpatients
45. Children of substance abusers: Overview of research findings
46. A central mechanism in the development of drug dependence
47. Antecedents of adolescent initiation into stages of drug abuse
48. Stages of progression in drug in drug involvement from adolescence to adulthood: Further evidence for the gateway theory
49. Genetic and environmental risk factors for cannabis use, abuse, dependence: A study of female twins
50. Effects of ’Preparing for the drug free years’ on parenting behavior and family interactions
51. The relationship between alcohol problems and the anxiety disorders
52. Efficacy of family therapy for drug use: Promising but not definitive
53. Project DARE: No effects at 10-year follow-up
54. Implications of genetic epidemiology for the prevention of substance use disorders
55. Comorbidity of substance use disorders with mood and anxiety disorders: Results of international consortium in psychiatric epidemiology
56. A comparison of mechanisms underlying substance use for early adolescent children of alcoholics and controls
57. Brief intervention for harm reduction with alcohol and older adolescents in a hospital emergency department
58. Progression of conduct disorder to antisocial personality disorder following treatment for adolescent substance abuse
59. Social phobia in a population based female adolescent twin sample: Comorbidity and associated suicidal related symptoms
60. Molecular basis of addiction states
61. Molecular neurobiology of drug addiction
62. Identifying high risk youth: Prevalence and patterns of adolescent drug abuse
63. Psychosocial predictors and consequences of drug use: A developmental perspective within a prospective study
64. The biology of impulsivity and suicidality
65. Multisystemic therapy for adolescent substance abuse and dependence
66. Psychiatric comorbidity and the 16 month trajectory of substance abusing and substance dependent juvenile offenders
67. Factors associated with the development of substance use disorders in depressed adolescents
68. Family factors in the etiology and treatment of youthful drug abuse
69. General and specific childhood factors for depression and drug disorders by early adulthood
70. An open trial of bupropion for ADHD in adolescents with substance abuse disorders and conduct disorders
71. Fluoxentine in drug-dependent delinquents with major depression: An open trial
72. An open trial of pemoline in drug-dependent delinquents with attention deficit hyperactivity disorder
73. Depression in substance-dependent delinquents
74. A 10 year study of sons of alcoholics: Preliminary results
75. Comorbidity of mental disorders in the post mortem diagnosis of completed suicides in children and adolescents
76. The relationship between sexual abuse among psychiatrically hospitalized adolescents
77. Direct and indirect latent variable parenting outcomes of two universal family-focused prevention program: Extending a public health oriented research base
78. Early childhood behavior and temperament predict later substance abuse
79. Evaluation and treatment of adolescent substance abuse: A decision tree method
80. Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention deficit/hyperactivity disorder
81. Influences on adolescent substance dependence, conduct disorders, depression, attention deficit hyperactivity disorder, and gender
82. Attention deficit hyperactivity disorder and psychoactive substance use disorders
83. Risk for substance use disorders in youth with child and adolescent onset bipolar disorder
84. Naltrexone for alcohol abuse
85. Pathways to alcohol problems and alcoholism: A developmental account of the evidence for multiple alcoholisms and for contextual contributions to risk